Ontak
FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors »
"The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved t"...
Read the FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors article »
Ontak
Ontak Patient Information including How Should I Take
In this Article
- What is denileukin diftitox (Ontak)?
- What are the possible side effects of denileukin diftitox (Ontak)?
- What is the most important information I should know about denileukin diftitox (Ontak)?
- What should I discuss with my health care provider before using denileukin diftitox (Ontak)?
- How should I use denileukin diftitox (Ontak)?
- What happens if I miss a dose (Ontak)?
- What happens if I overdose (Ontak)?
- What should I avoid while receiving denileukin diftitox (Ontak)?
- What other drugs will affect denileukin diftitox (Ontak)?
- Where can I get more information?
What should I discuss with my health care provider before using denileukin diftitox (Ontak)?
You should not use denileukin diftitox if you have ever had an allergic reaction to a diphtheria vaccine or to medicines containing interleukin-2 (IL-2).
If you have heart disease, you may need a dose adjustment or special tests.
FDA pregnancy category C. It is not known whether denileukin diftitox will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
It is not known whether denileukin diftitox passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
Some patients receiving denileukin diftitox have had permanent changes in their vision or ability to see colors. Talk with your doctor about your individual risk. Tell your doctor if you have any vision changes during your treatment.
How should I use denileukin diftitox (Ontak)?
Denileukin diftitox is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting. This medication must be given slowly, and the IV infusion can take at least 15 minutes to complete. During this time you will be observed for side effects.
Denileukin diftitox is usually given each day for 5 days, followed by 3 weeks off the medication.
To be sure this medication is helping your condition, your blood will need to be tested on a regular basis before and during your treatment. Visit your doctor regularly.
Additional Ontak Information
Ontak - User Reviews
Ontak User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Ontak sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.
Updated & New
